CRP remains the most extensively studied inflammatory marker in OSA, and prior meta-analyses and extensive cohort studies have consistently demonstrated higher CRP levels in patients with more severe disease, particularly in the presence of obesity [15,20,28]. Here, CRP is linked to obesity due to melanocortin 4 receptor deficiency.